Inspire Medical Systems
INSP
340 hedge funds and large institutions have $7.1B invested in Inspire Medical Systems in 2022 Q4 according to their latest regulatory filings, with 69 funds opening new positions, 123 increasing their positions, 109 reducing their positions, and 27 closing their positions.
156% more first-time investments, than exits
New positions opened: 69 | Existing positions closed: 27
151% more call options, than puts
Call options by funds: $99.7M | Put options by funds: $39.8M
120% more funds holding in top 10
Funds holding in top 10: 5 → 11 (+6)
42% more capital invested
Capital invested by funds: $5.01B → $7.1B (+$2.09B)
13% more funds holding
Funds holding: 301 → 340 (+39)
13% more repeat investments, than reductions
Existing positions increased: 123 | Existing positions reduced: 109
0.98% less ownership
Funds ownership: 98.66% → 97.68% (-0.98%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$72.4M |
| 2 |
Millennium Management
New York
|
+$43.9M |
| 3 |
William Blair Investment Management
Chicago,
Illinois
|
+$37.3M |
| 4 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$32.3M |
| 5 |
BlackRock
New York
|
+$27.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$74M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$53.6M |
| 3 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$51M |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$34.9M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$33.8M |
INSP Hedge Fund Activity: Q4 2022 in Review
340 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Inspire Medical Systems (INSP) for Q4 2022, worth a combined $7.1B — up 42% from $5.01B a quarter earlier.
Buyers outnumbered sellers: 69 funds opened new INSP positions and 27 closed out — a net gain of 42 holders — while 123 added to existing stakes and 109 trimmed.
The largest buyer was Assenagon Asset Management, opening a new position worth an estimated $72.4M. The largest seller was Macquarie Group, cutting an estimated $74M.
- 340 institutional investors held Inspire Medical Systems (INSP) as of Q4 2022, up from 301 in Q3 2022.
- Funds reported $7.1B of Inspire Medical Systems stock for Q4 2022, up 42% quarter-over-quarter.
- 69 funds opened new Inspire Medical Systems positions in Q4 2022 and 27 closed out, a net change of +42 holders.
- The largest Inspire Medical Systems buyer in Q4 2022 was Assenagon Asset Management, an estimated $72.4M added.
- The largest Inspire Medical Systems seller in Q4 2022 was Macquarie Group, an estimated $74M sold.
Based on aggregated 13F filings for Q4 2022.